Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | APLS | BMY | AMGN | GILD | GSK |
Company | Apellis Pharmaceuticals Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Gsk Plc ADR |
Price Information | |||||
Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
Open | 36.24 | 49.89 | 337.03 | 84.39 | 42.40 |
High | 37.83 | 50.04 | 338.70 | 84.65 | 42.42 |
Low | 36.10 | 48.94 | 334.61 | 83.43 | 41.46 |
Last | 36.73 | 49.02 | 335.95 | 83.90 | 41.62 |
Change | +1.10 | -0.72 | +3.03 | +0.01 | -0.81 |
% Change | +3.09% | -1.45% | +0.91% | +0.01% | -1.91% |
Volume | 1,760,000 | 8,841,400 | 1,626,200 | 8,798,200 | 6,510,300 |
20-Day Average Volume | 1,188,430 | 8,610,180 | 1,760,685 | 6,694,930 | 3,749,365 |
Previous Close | 35.63 | 49.74 | 332.92 | 83.89 | 42.43 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | Yes | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 38.37 | 49.09 | 329.59 | 80.07 | 43.27 |
20-Day Raw Stochastic | 23.16% | 55.24% | 84.75% | 89.62% | 4.98% |
20-Day Relative Strength | 46.17% | 54.18% | 57.67% | 71.87% | 46.79% |
Weighted Alpha | -28.56 | -11.20 | +27.09 | +18.24 | +10.01 |
Today's Opinion | 88% Sell | 56% Buy | 96% Buy | 88% Buy | 16% Buy |
Previous Opinion | 88% Sell | 72% Buy | 88% Buy | 88% Buy | 56% Buy |
Last Month's Opinion | 64% Sell | 40% Buy | 88% Buy | 56% Buy | 40% Buy |
Performance | |||||
5-Days | |||||
%Chg | -0.14% since 09/12/24 | +1.62% since 09/12/24 | +1.78% since 09/12/24 | +0.89% since 09/12/24 | -3.46% since 09/12/24 |
Low | 35.16 on 09/17/24 | 48.20 on 09/13/24 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 41.46 on 09/19/24 |
High | 38.55 on 09/13/24 | 50.41 on 09/17/24 | 339.00 on 09/18/24 | 84.65 on 09/19/24 | 43.62 on 09/16/24 |
1-Month | |||||
%Chg | -4.77% since 08/19/24 | -0.57% since 08/19/24 | +2.43% since 08/19/24 | +12.69% since 08/19/24 | +0.24% since 08/19/24 |
Low | 35.16 on 09/17/24 | 46.88 on 08/22/24 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 41.46 on 09/19/24 |
High | 41.94 on 09/09/24 | 50.75 on 09/04/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 44.67 on 08/27/24 |
3-Month | |||||
%Chg | -8.34% since 06/18/24 | +20.12% since 06/18/24 | +9.79% since 06/18/24 | +32.86% since 06/18/24 | +1.64% since 06/18/24 |
Low | 33.49 on 08/05/24 | 39.35 on 07/05/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 37.81 on 07/02/24 |
High | 42.47 on 07/16/24 | 51.19 on 07/29/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 44.67 on 08/27/24 |
6-Month | |||||
%Chg | -35.47% since 03/19/24 | -5.37% since 03/19/24 | +23.63% since 03/19/24 | +14.29% since 03/19/24 | -1.65% since 03/19/24 |
Low | 33.49 on 08/05/24 | 39.35 on 07/05/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 37.81 on 07/02/24 |
High | 59.91 on 04/01/24 | 54.47 on 03/28/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 45.92 on 05/15/24 |
Key Statistics | |||||
Market Capitalization, $K | 4,324,271 | 100,827,960 | 178,589,936 | 104,514,608 | 87,935,408 |
Shares Outstanding, K | 121,366 | 2,027,100 | 536,435 | 1,245,853 | 2,072,482 |
Annual Sales | 396,590,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 37,725,000,000 |
Annual Net Income | -528,630,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 6,129,940,000 |
Last Quarter Sales | 199,690,000 | 12,201,000,000 | 8,388,000,000 | 6,954,000,000 | 9,950,400,000 |
Last Quarter Net Income | -37,660,000 | 1,680,000,000 | 746,000,000 | 1,614,000,000 | 1,480,440,000 |
60-Month Beta | 0.88 | 0.46 | 0.61 | 0.18 | 0.66 |
Per-Share Information | |||||
Most Recent Earnings | -0.28 on 08/01/24 | 2.07 on 07/26/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 1.09 on 07/31/24 |
Latest Earnings Date | 11/06/24 | 10/31/24 | 10/29/24 | 11/05/24 | 11/06/24 |
Most Recent Dividend | N/A | 0.600 on 07/05/24 | 2.250 on 08/16/24 | 0.770 on 09/13/24 | 0.378 on 08/16/24 |
Next Ex-Dividends Date | N/A | 10/04/24 | 08/16/24 | 09/13/24 | 08/16/24 |
Ratios | |||||
Price/Earnings ttm | 0.00 | 36.12 | 17.89 | 17.67 | 10.23 |